SGD Pharma will showcase its enhanced portfolio of products and services at booth 8.0H24 during CPHI, taking place in Frankfurt, Germany, from October 28 to 30, 2025.
As part of the company’s strategic growth plan to expand its tubular glass offering in Europe, SGD Pharma has significantly reinforced its industrial and commercial footprint with the acquisition of Alphial, a tubular glass converting company manufacturing ampoules, vials and Ready to Use (RTU) products.
This move positions SGD Pharma as a key player in the tubular segment as well as its leadership in moulded, enabling greater responsiveness, increased capacity and innovation tailored to the evolving needs of the European pharma market. The acquisition of Alphial will ideally complement the company’s existing operations in Europe and tubular facility in Vemula, India, recently bolstered by a joint venture with Corning. Alphial will also be attending CPHI, and visitors can find out more about how the expansion is reshaping tubular glass packaging at booth 8.0G1.
New for CPHI 2025, SGD Pharma continues to lead with its flagship Sealian platform. This internal surface treatment for moulded glass vials creates a strong barrier coating that protects sensitive therapeutics, improves chemical durability (especially against alkaline solutions), and reduces interactions between drug products and packaging. Sealian is available in clear and amber glass for vial sizes, ranging from 3 to 500 ml and is suited for every route of administration (parenteral, oral, nasal).
Also on display at CPHI 2025
- IDENCY: now fully completed range of vials in 6, 10 and 20 ml, combining the chemical and mechanical resistance of moulded glass with external dimensions comparable with standard tubular glass for fill & finish lines.
- Sterinity EZ-fill®: SG EZ-Fill’s ready-to-use (RTU) moulded glass vials, offering sterile, flexible and high-quality solutions.
- Ensiemo: the full pharma-grade Type III vial and pipette packaging system, now available with tamper-evident and child-resistant caps.
- Velocity® Vials: SGD Pharma’s Type I tubular glass vials with external low-friction coating from Corning, designed to optimize fill & finish operations — reducing friction, improving throughput (20‑50 percent efficiency gains), lowering particulate generation by up to 96 percent.
CPHI, SGD Pharma will also introduce Proseal+, an advanced external treatment for moulded and tubular vials that enhances moisture and oxygen protection to extend shelf life of pharmaceutical contents.